Comparison of effectiveness of aspirin, clopidogrel and cilostazol monotherapy treatment in ischaemic stroke
Stroke is the third most common cause of disability and the second most common cause of death globally. Between 1990 and 2019, its prevalence increased by 70%. The prevalence of stroke increased from 7% in 2013 to 10.9% in 2018 in Indonesia. Because antiplatelet medication does not improve platelet...
Saved in:
Main Authors: | Endarwati Tuti, Kurniasih Khamdiyah Indah, Fauziah Fauziah, Sunarti Sunarti, Agus Salim Muh. |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2025-01-01
|
Series: | BIO Web of Conferences |
Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2025/03/bioconf_ichbs2025_01001.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Maurizio Paciaroni, et al.
Published: (2019-01-01) -
Comparative efficacy of clopidogrel-aspirin combination therapy versus aspirin monotherapy in preventing recurrent events in transient ischemic attack and minor stroke: a systematic review and meta-analysis
by: Ahmad Mujtaba Bhutto, et al.
Published: (2025-02-01) -
Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
by: Massimo Montalto, et al.
Published: (2011-01-01) -
THE INDONESIAN GOVERNMENT'S POLICY IN IMPROVING THE TEACHERS' QUALITY OF ELEMENTARY SCHOOL
by: Sunarti Sunarti
Published: (2022-12-01) -
Thrombin Generation in Acute Ischaemic Stroke
by: Ibrahim O. Balogun, et al.
Published: (2016-01-01)